EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Potential of PD-1 and PD-L1 as Prognostic and Predictive Biomarkers in Colorectal Adenocarcinoma Based on TILs Grading

Nur Rahmah Rasyid iD, Upik Anderiani Miskad, Muhammad Husni Cangara iD, Syarifuddin Wahid, Djumadi Achmad, Suryani Tawali iD, Mardiati Mardiati

Current Oncology · 2024

DOI: 10.3390/curroncol31120552 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Oncology, 2024. Verfasst von Nur Rahmah Rasyid und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomical Pathology, Faculty of Medicine, Hasanuddin University, Makassar 90245, Indonesia. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Lymphocytes, Tumor-Infiltrating, B7-H1 Antigen, Adenocarcinoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Colorectal cancer (CRC) is a prevalent malignancy with a high mortality rate. Tumor-infiltrating lymphocytes (TILs) play a crucial role in the immune response against tumors. Programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) are key immune checkpoints regulating T cells in the tumor microenvironment. This study aimed to assess the relationships among PD-1 expression on TILs, PD-L1 expression in tumors, and TIL grading in colorectal adenocarcinoma.

Methods

A cross-sectional design was employed to analyze 130 colorectal adenocarcinoma samples. The expression of PD-1 and PD-L1 was assessed through immunohistochemistry. A semi-quantitative scoring system was applied. Statistical analysis with the chi-square test was performed to explore correlations, with the data analyzed in SPSS version 27.

Results

PD-1 expression on TILs significantly correlated with a higher TIL grading (p < 0.001), while PD-L1 expression in tumors showed an inverse correlation with TIL grading (p < 0.001).

Conclusions

The expression of PD-1 on TILs and PD-L1 on tumor cells correlated significantly with the grading of TILs in colorectal adenocarcinoma. This finding shows potential as a predictive biomarker for PD-1/PD-L1 blockade therapy. Further studies are needed to strengthen these results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsLymphocytes, Tumor-InfiltratingB7-H1 AntigenAdenocarcinomaBiomarkers, TumorProgrammed Cell Death 1 ReceptorHumansMaleFemaleMiddle AgedPrognosisAgedCross-Sectional StudiesNeoplasm GradingAdultAged, 80 and over

Stichwörter der Autor:innen

PD-1PD-L1biomarkerscolorectal cancerimmunotherapytumor infiltrating lymphocytes

Substanzen

B7-H1 AntigenBiomarkers, TumorProgrammed Cell Death 1 ReceptorCD274 protein, humanPDCD1 protein, human

Autor:innen und Institutionen

  • Department of Anatomical Pathology, Faculty of Medicine, Hasanuddin University, Makassar 90245, Indonesia.
  • Anatomical Pathology Laboratory, Hasanuddin University Hospital, Makassar 90245, Indonesia.
  • Department of Public Health, Faculty of Medicine, Hasanuddin University, Makassar 90245, Indonesia.

ORCID-Profile: Nur Rahmah Rasyid, Muhammad Husni Cangara, Suryani Tawali

Zitieren

APA

Rasyid, N. R., Miskad, U. A., Cangara, M. H., Wahid, S., Achmad, D., Tawali, S., & Mardiati, M. (2024). The Potential of PD-1 and PD-L1 as Prognostic and Predictive Biomarkers in Colorectal Adenocarcinoma Based on TILs Grading. Current Oncology. https://doi.org/10.3390/curroncol31120552

Vancouver

Rasyid NR, Miskad UA, Cangara MH, Wahid S, Achmad D, Tawali S, et al. The Potential of PD-1 and PD-L1 as Prognostic and Predictive Biomarkers in Colorectal Adenocarcinoma Based on TILs Grading. Current Oncology. 2024. doi:10.3390/curroncol31120552

BibTeX
@article{Rasyid2024,
  author = {Rasyid, Nur Rahmah and Miskad, Upik Anderiani and Cangara, Muhammad Husni and Wahid, Syarifuddin and Achmad, Djumadi and Tawali, Suryani and Mardiati, Mardiati},
  title = {The Potential of PD-1 and PD-L1 as Prognostic and Predictive Biomarkers in Colorectal Adenocarcinoma Based on TILs Grading},
  journal = {Current Oncology},
  year = {2024},
  doi = {10.3390/curroncol31120552}
}
Kostenlos starten →